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Surgery for pulmonary aspergillosis was evaluated in 20 
patients who underwent surgery. These included pulmo-
nary aspergillosis in 17, bronchial aspergillosis in 2 and 
pleural aspergillosis in 1, respectively. The operative pro-
cedures were mainly lobectomy and segmentectomy except 
for one in whom fenestration was carried out. With ad-
vances in development of drugs such as fluconazole and 
miconazole, surgical outcome was improved without any 
operative death related to surgery as far as healthy polmo-
nary tissues are preserved. Nevertheless, it is emphasized 
that severity of preexisting disorder should be precisely 
assessed prior to surgery.
Fig. 1. Symptoms
Introduction 
Since pulmonary aspergillosis had been reported in 1842 
by Bennet, the treatment of choice is a great item of 
concern. In particular, surgical decision-making for pulmo-
nary or pleural aspergillosis is one of the major dilemmas 
shared by the chest physician and the thoracic surgeon. The 
choice of methods is contentious. The purpose of this study 
is to analyze the surgical outcome and also to evaluate the 
validity of surgery for pulmonary aspergillosis on the basis 
of a result of clinical experience.
Patients 
During the past 11 year period from January 1981 to 
December 1991, twenty-three patients with pulmonary 
aspergillosis were operated upon at the First Department of 
Surgery, Nagasaki University School of Medicine. The 
ages ranged from 19 to 70 with an average of 53. The main 
symptoms were cough and sputum with hemoptysis in 17 
(73.9%). Asymptomatic four patients were included in this 
series. Another symptoms were fever in three and exer-
tional dyspnea in one (Fig. 1). 
 Primary aspergilloma was seen in six. Underlying dis-
eases were pulmonary tuberculosis in eight, bronchiectasis 
in two, and single cases of pneumonia, chronic brnonchitis,
lung abscess and chronic empyema, respectively (Fig. 2). 
Aspergillomas mostly favored bilateral upper lobes, in 
particular, right upper lobe 65% of patients (Fig. 3). 
  The air-crescent sign was manifested as a radiological 
finding of pulmonary aspergillomas in this series. The 
cavitary shadow was revealed in a few cases. The air-fluid 
level shadow is characteristic of pleural aspergilloma (Fig. 
4). 
  The surgical procedure of choice was mainly lobectomy. 
Segmentectomy was also used to preserve pulmonary func-
tion, And also fenestration was applied for palliation (Fig. 
5). Main drugs preoperatively prescribed were AMPH and 
fluconazole (Fig. 6). It is indicated that surgery is required
Fig. 2. Underlying Diseases
pyema. Recent advances in new drugs promise a better 
surgical result and promote the improvement of surgical 
outcome.
Fig. 3. Location of Aspergilloma
Fig. 4. Radiological Findings
Fig. 5. Surgical Procedure
Discussion 
The first operative resection of an aspergilloma was carried 
out by Gerstl, Wideman and Newmann in 1948 (1). This 
rare disease continues to present as a major therapeutic 
challenge. It is accepted that pulmonary aspergillosis is 
represented as a complication of preexisting pulmonary 
diseases with invasion of damaged parenchym. In Japan, 
lung tuberculosis is a common preexisting disease of pul-
monary aspergillosis. The clinical manifestation is progres-
sive pulmonary infection and massive hemoptysis. 
Difficulty in determination of surgical indication exists in 
high mortality rate in the particular patients if surgery is 
undertaken. In fact, surgical strategy has been extended for 
the treatment of this disease by the development of potent 
drugs. 
 Established method of diagnosis in application of the 
molecular genetics serves as early detection and realization 
of disease progression in addition to serology (2). With 
development of new drugs, the treatment of this disease has 
progressed. Approach to the lesions by direct drug instil-
lation was devised to avoid the side-effect of drugs (3) and 
also to anticipate the effectiveness of drugs. However, drug 
therapy has not proved to be of great value. Surgery is 
mandated for those who have no effect of drugs. It is now 
possible to precisely assess radiologic features of alteration 
in appearance of central mass and movement of the fungus 
ball by changing the position of the patient. 
  In general, surgical resection has been reserved for 
progressive aspergillosis and for those in whom the compli-
cations of this disease are life-threatening (4). In this series, 
the surgical outcome was satisfactory as far as healthy 
pulmonary tissues are preserved. On the contrary, surgeons 
should be aware of a poor result which is related to the 
severity of preexisting disorder including the defensive 
immunity of a host at the time of operation (5).
Fig. 6. Preoperative Treatment
for patients treated with miconazole and flucytosine re-
cently developed. The surgical outcome was satisfactory 
except for one case of postoperative complication of em-
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